TrademarkDir
MAKE CANCER A BENIGN EXPERIENCE
LIVE

Serial Number

90701065

Owner

Earli Inc.

Attorney

Ted D. Karr

First Use Date

Jan 4, 2023

Filing Date

May 10, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MAKE CANCER A BENIGN EXPERIENCE Trademark

Serial Number: 90701065 • Registration: 7287794

MAKE CANCER A BENIGN EXPERIENCE is a trademark filed by Earli Inc. on May 10, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Earli Inc. (9 trademarks)

Mountain View, CA 94022

Entity Type: 03

Trademark Details

Filing Date

May 10, 2021

Registration Date

January 23, 2024

First Use Anywhere

January 4, 2023

First Use in Commerce

January 24, 2023

Published for Opposition

June 14, 2022

Goods & Services

Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer

Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 23, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 19, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 18, 2023 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2023 CRFA
ASSIGNED TO LIE
Dec 7, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 10, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 10, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 24, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 23, 2023 AITU
USE AMENDMENT FILED
Feb 1, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 1, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 9, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 14, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 25, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 10, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 10, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 10, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 10, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 6, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 23, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 23, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 23, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 13, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 13, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 13, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 13, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 10, 2021 NWOS
NEW APPLICATION ENTERED
May 13, 2021 NWAP

Related Trademarks

More from this Owner

PROGRAMMING CANCER

PROGRAMMING CANCER

PROGRAM CANCER AGAINST ITSELF

PROGRAM CANCER AGAINST ITSELF

TURN CANCER AGAINST ITSELF

TURN CANCER AGAINST ITSELF

TURN CANCER AGAINST ITSELF

TURN CANCER AGAINST ITSELF

TURN CANCER AGAINST ITSELF

TURN CANCER AGAINST ITSELF

SYNTHETIC BIOPSY

SYNTHETIC BIOPSY